Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-059931
Filing Date
2013-11-20
Accepted
2013-11-20 16:44:23
Documents
1
Period of Report
2013-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd395949.html 4  
1 FORM 4 rrd395949.xml 4 4023
  Complete submission text file 0001181431-13-059931.txt   5354
Mailing Address 2100 SYNTEX COURT MISSISSAUGA A6 L5N 7K9
Business Address C/O PATHEON PHARMACEUTICALS SERVICES INC 4721 EMPEROR BOULEVARD, SUITE 200 DURHAM NC 27703 905-821-4001
PATHEON INC (Issuer) CIK: 0001400431 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations

Mailing Address 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017
Business Address
Lagarde Michel (Reporting) CIK: 0001518973 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54283 | Film No.: 131233350